Chemoinformaics analysis of Epoxycampholenic aldehyde
| Molecular Weight | 168.236 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
| Exact Molecular Weight | 168.115 | nRing | 2 |
| Solubility: LogS | -2.153 | nHRing | 1 |
| Solubility: LogP | 1.624 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.9727 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.464 |
| Synth | 4.677 |
| Natural Product Likeliness | 2.376 |
| NR-PPAR-gamma | 0.162 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.547 |
| MDCK | 0.0000272 |
| BBB | 0.981 |
| PPB | 0.38066 |
| VDSS | 1.33 |
| FU | 0.731024 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.338 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.853 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.189 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.687 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.313 |
| CL | 15.851 |
| T12 | 0.29 |
| hERG | 0.019 |
| Ames | 0.088 |
| ROA | 0.032 |
| SkinSen | 0.947 |
| Carcinogencity | 0.693 |
| EI | 0.984 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.042 |
| Antiviral | No |
| Prediction | 0.931396 |